Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMKFZW5)

Drug Name

HC-5404 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 1	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting PRKR-like endoplasmic reticulum kinase (PERK)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Tricyclic isoxazoloquinazoline derivative 2	DMH4TY1	N. A.	N. A.	Patented	[3]
Tricyclic isoxazoloquinazoline derivative 4	DM8VIM4	N. A.	N. A.	Patented	[3]
Tricyclic isoxazoloquinazoline derivative 3	DML2PWF	N. A.	N. A.	Patented	[3]
Phenylpyrrolidinone derivative 3	DMPZKQN	N. A.	N. A.	Patented	[3]
Indoline derivative 6	DMU5KWC	N. A.	N. A.	Patented	[3]
Tricyclic isoxazoloquinazoline derivative 1	DM6QSND	N. A.	N. A.	Patented	[3]
Phenylpyrrolidinone derivative 1	DMPAI5C	N. A.	N. A.	Patented	[3]
Phenylpyrrolidinone derivative 5	DMZSTLH	N. A.	N. A.	Patented	[3]
Indoline derivative 3	DM20YBJ	N. A.	N. A.	Patented	[3]
Indoline derivative 11	DM6JR3X	N. A.	N. A.	Patented	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
PRKR-like endoplasmic reticulum kinase (PERK)	TT5OU0D	E2AK3_HUMAN	Inhibitor	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT04834778) A Multicenter, Open-label, Phase 1a Study of HC-5404-FU in Subjects With Advanced Solid Tumors. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of HiberCell
3	Protein kinase R(PKR)-like endoplasmic reticulum kinase (PERK) inhibitors: a patent review (2010-2015).Expert Opin Ther Pat. 2017 Jan;27(1):37-48.